Perceptive

Technology Solutions

Takara Bio selects Genedata software to automate, standardize NGS data analysis

Thursday, November 6, 2014 12:35 PM

Takara Bio, a global biotechnology company based in Shiga, Japan, has chosen Genedata Expressionist for Genomic Profiling as its key software platform for next-generation sequencing (NGS) data. Genedata, headquartered in Switzerland, is a provider of advanced software solutions for drug discovery and life science research.

More... »

Theorem Clinical Research

DSG, OPKO Health ink agreement for trial management solution

Wednesday, November 5, 2014 12:50 PM

OPKO Health, a multinational pharmaceutical and diagnostics company, has selected Malvern, Pa.-based DSG’s eCaseLink integrated suite for self-building of harmonized electronic data capture (EDC), IWRS, drug safety event capture and case reporting and CTMS systems. DSG’s team will support the OPKO team and their site users.

More... »

Quest Diagnostics

Certara updates PK/PD Phoenix Platform

Monday, November 3, 2014 02:28 PM

Certara, a Princeton, N.J.-based global technology-enabled drug development and drug safety consultancy, has launched version 1.4 of its Phoenix product family.

More... »

TNT launches TrialDat

Thursday, October 30, 2014 12:23 PM

TNT, a U.K. express delivery company, has launched TrialDat, a tool developed specifically for the clinical research sector, which captures end-to-end data on a single platform, offering a dashboard view of all clinical material transport flows.

More... »

BloodCenter of Wisconsin launches next-generation sequencing HemeOnc Panel

Thursday, October 30, 2014 12:22 PM

BloodCenter of Wisconsin's Diagnostic Laboratories has announced the availability of a comprehensive cancer mutation HemeOnc Panel using next-generation sequencing (NGS) technology. The NGS panel is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.

More... »

Abbott acquires medical device company Topera

Thursday, October 30, 2014 12:19 PM

Abbott has entered into an agreement to purchase Topera, a Menlo Park, Calif.-based, private, venture-backed medical device company focused on developing innovative electrophysiology technologies to improve the diagnosis and treatment of atrial fibrillation, one of the most common heart rhythm disorders in the world. Through this acquisition, Abbott enters the catheter-based electrophysiology market, an approximately $3 billion global market that has been growing annually at double-digit rates.

More... »

Booz Allen Hamilton acquires Epidemico

Thursday, October 30, 2014 12:15 PM

Booz Allen Hamilton, a Boston, Mass.-based provider of management consulting, technology and engineering services, has acquired Epidemico, a Boston informatics company.

More... »

eClinicalWorks chooses Exostar’s new identity proofing authentication service

Thursday, October 30, 2014 12:13 PM

Exostar, a Herndon, Va.-based information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, has launched its new turn-key, Software-as-a-Service (SaaS) identity proofing and second factor credential authentication solution, ProviderPass. eClinicalWorks, a Westborough, Mass.-based provider of ambulatory healthcare IT solutions, has selected ProviderPass to expand its comprehensive electronic health records (EHR) product suite to include electronic prescribing of controlled substances (EPCS).

More... »

Cepheid, FIND, Rutgers collaborate on Xpert MTB/RIF test

Wednesday, October 29, 2014 01:22 PM

Cepheid, a Sunnyvale, Calif.-based molecular diagnostics company, FIND, a Switzerland-based international nonprofit organization and Rutgers New Jersey Medical School are collaborating to develop Xpert MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis (TB) with increased sensitivity to aid in detection of patients with smear-negative TB, which often is associated with HIV co-infection. The collaboration also is receiving additional support from the National Institute of Allergy and Infectious Diseases at the NIH.

More... »

ClinGen launches patient portal GenomeConnect

Wednesday, October 29, 2014 01:20 PM

The Clinical Genome Resource (ClinGen), a NIH-funded resource dedicated to analyzing data from thousands of clinical genetics tests each year, has launched a new patient portal, GenomeConnect.

More... »


CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs